Drug Sales in Emerging Markets to Match U.S. by 2016

China, India, Brazil, Russia are among 16 emerging markets that will make up almost one-third of global drug spending within four years, as newly wealthy people and nations spend more on health care, a report shows.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.